SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

The Valens Company Inc. VLNS.TO TSX

Toronto Stock Exchan • Healthcare • Drug Manufacturers - Specialty & Generic • CA • CAD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

The Valens Company Inc. (VLNS.TO) 是一家制药 - 专科与仿制药公司，属于医疗保健行业, 目前交易价格为 $1.01. 其SharesGrow评分为 28/100, 表明较弱的投资特征， 7项中通过0项.

财务数据: 营收为 $78M, +37569.2%/yr 平均增长. 净利润为 $49M (亏损), 增长率为 -98.2%/yr. 净利润率为 -62.7% (负值). 毛利率为 22.1% (-16.7 pp 趋势).

资产负债表: 总债务为 $15M 对比 $259M 股东权益 (D/E比率 0.06, 保守). 流动比率为 1.97 (流动性强). 资产负债率为 4.5%. 总资产: $345M.

SharesGrow 7项标准细分: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 14/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

VLNS.TO SharesGrow 评分概览

37/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

价值 0/100

估值 — P/E, PEG, Forward PEG

成长 58/100

财务数据 — 平均增长

过去 0/100

强劲 — 趋势

健康 67/100

资产负债表 — D/E比率, 流动比率为

护城河 14/100

毛利率为 + market cap

未來 0/100

分析师展望 — 为买入

收入 10/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — VLNS.TO

No analyst coverage available for this stock.

VLNS.TO: +37569.2%/yr 营收为, -98.2%/yr 净利润为平均增长. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

资产负债表 VLNS.TO: D/E比率 0.06 (保守), 流动比率为 1.97 (流动性强). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

VLNS.TO: 毛利率为 22.1% (-16.7 pp 趋势), N/A market cap. Moat (0-100): margin (35%) + 趋势 (15%) + market cap (30%) + 营收为 (20%). Score 14/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

VLNS.TO: 净利润率为 -62.7%. 负值. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间0.76-3.79

成交量57.43K

30日平均成交量130.04K

Beta（1年）0.00

股份统计

EPS（TTM）-1.15

流通股数$42.52M

IPO日期2020-04-16

员工数445

首席执行官Jeffrey Fallows CFA

财务亮点与比率

营收（TTM）$78.18M

毛利润$17.24M

EBITDA$-40.28M

净利润$-49.03M

营业利润$-53.99M

现金总额$30.42M

总负债$15.38M

净负债$-670K

总资产$344.68M

市盈率（P/E）-0.9

分析师预测

公司信息

国家CA

交易所Toronto Stock Exchan

货币CAD

ISINCA91914P6030

股价走势

VLNS.TO

The Valens Company Inc. ↗ · Toronto Stock Exchan

Healthcare • Drug Manufacturers - Specialty & Generic

0.76 52周区间 3.79

其他人也在看

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言